NovaSignal Announces First Patient Enrolled in Innovative Clinical Trial
NovaSignal Corp., a medical technology and data company specializing in assessing cerebral blood flow, today announced enrollment of the first patient in its clinical trial evaluating the advantages of the NovaGuide Intelligent Ultrasound in detecting a patent foramen ovale (PFO) compared to traditional ultrasound methods. October 13: Newsr October 13: One News Page